{"id":"W4417011298","doi":"10.1182/blood-2025-2369","title":"INO-transit: Inotuzumab ozogamicin treatment prior to chimeric antigen receptor T-cell therapy in Relapsed/Refractory B-cell acute lymphoblastic leukemia: Real-world patient characteristics and outcomes in Spain, the UK and US","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Société de Protection des Forêts contre les Insectes et Maladies","funders":"","keywords":"Blinatumomab; Chimeric antigen receptor; Gemtuzumab ozogamicin; Minimal residual disease; Salvage therapy; Acute lymphocytic leukemia; Cytokine release syndrome; Hematopoietic stem cell transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001162661,0.000184839,0.0003505006,0.0007155457,0.0002256632,0.0009392657,0.000483152,0.0003605306,0.001630606],"category_scores_gemma":[0.00342029,0.0002042061,0.0004134359,0.001864131,0.0003045401,0.0004849251,0.0007101145,0.000473478,0.0002745816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001693245,"about_ca_system_score_gemma":0.001041218,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0176822,"about_ca_topic_score_gemma":0.01554168,"domain_scores_codex":[0.9989898,0.000274361,0.0001667203,0.0002035361,0.000199066,0.0001665206],"domain_scores_gemma":[0.9949003,0.0005493168,0.003445305,0.0001588298,0.0003844289,0.0005619629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002332323,0.00009926615,0.9902809,0.00006342149,0.00009385674,0.000181457,0.0001245088,0.0001817034,0.00009320861,0.00003306797,0.001489012,0.005027202],"study_design_scores_gemma":[0.0002554894,0.0005408733,0.9953735,0.00006815165,0.0000835079,0.000721196,0.0004930372,0.0002893395,0.0001038787,0.00003159634,0.002025972,0.00001353848],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994293,0.000799662,0.00005578738,0.0001515104,0.000008110412,0.00003184735,0.003930956,0.000007130121,0.0007220263],"genre_scores_gemma":[0.994547,0.0004194508,0.0001072424,0.0001501415,0.00002141194,0.00003213823,0.004560494,0.000006059893,0.0001561321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0176822,"threshold_uncertainty_score":0.03515857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01114862187194786,"score_gpt":0.2673398979002521,"score_spread":0.2561912760283042,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}